Announced
Financials
Sources
Tags
France
biopharmaceutical company
Pending
Majority
Pharmaceuticals
Friendly
Private
Acquisition
Single Bidder
Cross Border
Synopsis
L-GAM, a long-term oriented investment firm, and French Tech Souverainete, an investment fund, agreed to invest €80m ($86m) in Biose Industrie, a contract development and manufacturing organization, specialized in Live biotherapeutic products. "As an industrial partner naturally intent on serving our clients, we are proud to contribute with them to improving the health of all the patients affected by their research programmes,” Adrien Nivoliez, Biose Industrie CEO.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.